The use of zenocutuzumab for NRG1 fusion-positive tumors.

Clin Adv Hematol Oncol

Memorial Sloan Kettering Cancer Center, New York, New York.

Published: December 2024

Download full-text PDF

Source

Publication Analysis

Top Keywords

zenocutuzumab nrg1
4
nrg1 fusion-positive
4
fusion-positive tumors
4
zenocutuzumab
1
fusion-positive
1
tumors
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!